JP6877449B2 - ピロロ[3,2−d]ピリミジン化合物を調製するための方法、及びそれらの中間体 - Google Patents

ピロロ[3,2−d]ピリミジン化合物を調製するための方法、及びそれらの中間体 Download PDF

Info

Publication number
JP6877449B2
JP6877449B2 JP2018540720A JP2018540720A JP6877449B2 JP 6877449 B2 JP6877449 B2 JP 6877449B2 JP 2018540720 A JP2018540720 A JP 2018540720A JP 2018540720 A JP2018540720 A JP 2018540720A JP 6877449 B2 JP6877449 B2 JP 6877449B2
Authority
JP
Japan
Prior art keywords
formula
acid
compound represented
compound
process according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2018540720A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019505531A5 (cg-RX-API-DMAC10.html
JP2019505531A (ja
Inventor
ディン,ツァオジョン
スン,フェイ
フゥー,インフゥー
シュウ,イーロン
ジャオ,ルイ
ヤン,リン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chia Tai Tianqing Pharmaceutical Group Co Ltd
Original Assignee
Chia Tai Tianqing Pharmaceutical Group Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chia Tai Tianqing Pharmaceutical Group Co Ltd filed Critical Chia Tai Tianqing Pharmaceutical Group Co Ltd
Publication of JP2019505531A publication Critical patent/JP2019505531A/ja
Publication of JP2019505531A5 publication Critical patent/JP2019505531A5/ja
Application granted granted Critical
Publication of JP6877449B2 publication Critical patent/JP6877449B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
JP2018540720A 2016-02-05 2017-02-04 ピロロ[3,2−d]ピリミジン化合物を調製するための方法、及びそれらの中間体 Active JP6877449B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN201610082028.3 2016-02-05
CN201610082028.3A CN107043378A (zh) 2016-02-05 2016-02-05 一种吡咯并[3,2-d]嘧啶类化合物的制备方法及其中间体
PCT/CN2017/072893 WO2017133686A1 (zh) 2016-02-05 2017-02-04 一种吡咯并[3,2-d]嘧啶类化合物的制备方法及其中间体

Publications (3)

Publication Number Publication Date
JP2019505531A JP2019505531A (ja) 2019-02-28
JP2019505531A5 JP2019505531A5 (cg-RX-API-DMAC10.html) 2020-02-27
JP6877449B2 true JP6877449B2 (ja) 2021-05-26

Family

ID=59500148

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018540720A Active JP6877449B2 (ja) 2016-02-05 2017-02-04 ピロロ[3,2−d]ピリミジン化合物を調製するための方法、及びそれらの中間体

Country Status (28)

Country Link
US (2) US10654856B2 (cg-RX-API-DMAC10.html)
EP (1) EP3412673B1 (cg-RX-API-DMAC10.html)
JP (1) JP6877449B2 (cg-RX-API-DMAC10.html)
KR (1) KR102371500B1 (cg-RX-API-DMAC10.html)
CN (2) CN107043378A (cg-RX-API-DMAC10.html)
AR (1) AR107549A1 (cg-RX-API-DMAC10.html)
AU (1) AU2017214134B2 (cg-RX-API-DMAC10.html)
BR (1) BR112018015879B1 (cg-RX-API-DMAC10.html)
CA (1) CA3013520C (cg-RX-API-DMAC10.html)
CL (1) CL2018002094A1 (cg-RX-API-DMAC10.html)
DK (1) DK3412673T3 (cg-RX-API-DMAC10.html)
EA (1) EA034581B1 (cg-RX-API-DMAC10.html)
ES (1) ES2852323T3 (cg-RX-API-DMAC10.html)
HR (1) HRP20210103T1 (cg-RX-API-DMAC10.html)
HU (1) HUE053455T2 (cg-RX-API-DMAC10.html)
IL (1) IL260999B (cg-RX-API-DMAC10.html)
LT (1) LT3412673T (cg-RX-API-DMAC10.html)
MX (1) MX374298B (cg-RX-API-DMAC10.html)
MY (1) MY190551A (cg-RX-API-DMAC10.html)
NZ (1) NZ744885A (cg-RX-API-DMAC10.html)
PH (1) PH12018501642A1 (cg-RX-API-DMAC10.html)
PL (1) PL3412673T3 (cg-RX-API-DMAC10.html)
PT (1) PT3412673T (cg-RX-API-DMAC10.html)
SG (1) SG11201806685VA (cg-RX-API-DMAC10.html)
SI (1) SI3412673T1 (cg-RX-API-DMAC10.html)
TW (1) TW201728590A (cg-RX-API-DMAC10.html)
UA (1) UA124100C2 (cg-RX-API-DMAC10.html)
WO (1) WO2017133686A1 (cg-RX-API-DMAC10.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9815850B2 (en) 2016-02-05 2017-11-14 Denali Therapeutics Inc. Compounds, compositions and methods
CN107043380A (zh) * 2016-02-05 2017-08-15 正大天晴药业集团股份有限公司 一种tlr7激动剂的马来酸盐、其晶型c、晶型d、晶型e、制备方法和用途
BR112021015577A2 (pt) 2019-02-08 2021-10-05 Research & Business Foundation Sungkyunkwan University Complexo-colesterol agonista do receptor toll-like 7 ou 8 e uso do mesmo
CN115666637A (zh) 2020-03-02 2023-01-31 蛋白科技先锋 基于病原体细胞壁骨架的模拟活病原体的纳米粒子及其制备方法
EP4194008A4 (en) 2020-08-04 2025-01-08 Progeneer Inc. Kinetically acting adjuvant ensemble
WO2022031021A1 (ko) 2020-08-04 2022-02-10 성균관대학교산학협력단 동력학적 제어가 가능한 아주번트를 포함하는 mrna 백신
US20230277525A1 (en) 2020-08-04 2023-09-07 Progeneer Inc Conjugate of functional drug and toll-like receptor 7 or 8 agonist of which active site is temporarily inactivated and use thereof
EP4463229A1 (en) 2022-01-12 2024-11-20 Denali Therapeutics Inc. Crystalline forms of (s)-5-benzyl-n-(5-methyl-4-oxo-2, 3,4,5- tetrahydropyrido [3,2-b] [l,4]oxazepin-3-yl)-4h-l,2,4-triazole-3-carboxamide
WO2025110816A1 (ko) 2023-11-23 2025-05-30 프로지니어 주식회사 암의 치료를 위한 활성화 부위가 일시적으로 비활성화된 톨-유사 수용체 7 또는 8 작용자와 항암 치료의 병용요법

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009082247A1 (en) 2007-12-21 2009-07-02 Industrial Research Limited Process for preparing immucillins having a methylene link
UY32306A (es) 2008-12-09 2010-07-30 Gilead Sciences Inc Derivados de pteridinona y pirimidinodiazepinona y composiciones farmacéuticas que modulan en forma selectiva los receptores tipo toll, métodos y usos
MX386924B (es) * 2012-10-10 2025-03-19 Janssen Sciences Ireland Uc Derivados pirrolo[3,2-d]pirimidínicos para el tratamiento de infecciones víricas y otras enfermedades.
JP6216387B2 (ja) * 2012-11-20 2017-10-18 グラクソスミスクライン・リミテッド・ライアビリティ・カンパニーGlaxoSmithKline LLC 新規化合物
SMT201700378T1 (it) * 2012-11-20 2017-09-07 Glaxosmithkline Llc Nuovi composti
WO2015168269A1 (en) * 2014-05-01 2015-11-05 Novartis Ag Compounds and compositions as toll-like receptor 7 agonists
CN112898308B (zh) 2014-08-15 2026-08-07 正大天晴药业集团股份有限公司 作为tlr7激动剂的吡咯并嘧啶化合物
CN105367576A (zh) 2014-08-15 2016-03-02 正大天晴药业集团股份有限公司 作为tlr7激动剂的吡咯并嘧啶化合物
KR102112192B1 (ko) * 2015-11-05 2020-05-19 치아타이 티안큉 파마수티컬 그룹 주식회사 Tlr7 효능제로서의 7-(티아졸-5-일)피롤로피리미딘 화합물
CN107043377A (zh) * 2016-02-05 2017-08-15 正大天晴药业集团股份有限公司 一种tlr7激动剂的三氟乙酸盐、晶型b及其制备方法、药物组合物和用途
CN107043380A (zh) * 2016-02-05 2017-08-15 正大天晴药业集团股份有限公司 一种tlr7激动剂的马来酸盐、其晶型c、晶型d、晶型e、制备方法和用途
CN107043379A (zh) 2016-02-05 2017-08-15 正大天晴药业集团股份有限公司 一种tlr7激动剂的晶型a、其制备方法和医药用途

Also Published As

Publication number Publication date
EP3412673B1 (en) 2020-11-25
HK1259183A1 (zh) 2019-11-29
LT3412673T (lt) 2021-03-10
IL260999B (en) 2021-02-28
BR112018015879B1 (pt) 2024-02-15
CN108602832B (zh) 2020-10-09
HUE053455T2 (hu) 2021-06-28
US10654856B2 (en) 2020-05-19
CA3013520A1 (en) 2017-08-10
HRP20210103T1 (hr) 2021-03-05
WO2017133686A1 (zh) 2017-08-10
PH12018501642B1 (en) 2019-06-03
CN107043378A (zh) 2017-08-15
KR102371500B1 (ko) 2022-03-07
AU2017214134B2 (en) 2020-08-27
PL3412673T3 (pl) 2021-07-26
UA124100C2 (uk) 2021-07-21
KR20180104724A (ko) 2018-09-21
EP3412673A4 (en) 2019-07-03
EP3412673A1 (en) 2018-12-12
BR112018015879A2 (pt) 2018-12-26
PH12018501642A1 (en) 2019-06-03
EA201891769A1 (ru) 2019-04-30
AU2017214134A1 (en) 2018-08-23
PT3412673T (pt) 2021-02-15
AR107549A1 (es) 2018-05-09
CA3013520C (en) 2022-07-19
ES2852323T3 (es) 2021-09-13
SG11201806685VA (en) 2018-09-27
US20190040072A1 (en) 2019-02-07
MY190551A (en) 2022-04-27
JP2019505531A (ja) 2019-02-28
CL2018002094A1 (es) 2018-12-07
US20200239484A1 (en) 2020-07-30
SI3412673T1 (sl) 2021-04-30
MX2018009502A (es) 2018-12-11
EA034581B1 (ru) 2020-02-21
MX374298B (es) 2025-03-06
NZ744885A (en) 2022-07-01
TW201728590A (zh) 2017-08-16
CN108602832A (zh) 2018-09-28
DK3412673T3 (da) 2021-01-18

Similar Documents

Publication Publication Date Title
EP3412673B1 (en) Method for preparing pyrrolo[3,2-d]pyrimidine compound, and intermediates thereof
KR102112192B1 (ko) Tlr7 효능제로서의 7-(티아졸-5-일)피롤로피리미딘 화합물
JP6889171B2 (ja) Tlr7アゴニスト結晶形a、その調製方法及び使用
JP6877450B2 (ja) Tlr7アゴニストのトリフルオロ酢酸塩及びその結晶形b、調製方法、並びに使用
JP6898336B2 (ja) Tlr7アゴニストのマレイン酸塩、その結晶形c、d及びe、マレイン酸塩及び結晶形の調製方法及び使用
CZ20003871A3 (cs) Dihydropyrimidiny, způsob jejich výroby, léčiva tyto látky obsahující a jejich použití
JP2011528025A (ja) 新規化学化合物
JP2011528025A6 (ja) 新規化学化合物
JP5209314B2 (ja) ケモカイン結合複素環式化合物の塩及びその使用方法
HK1259183B (en) Method for preparing pyrrolo[3,2-d]pyrimidine compound, and intermediates thereof
EP0578419B1 (en) Pyridine derivatives and pharmaceutical compositions containing them
HK1259182B (en) Tlr7 agonist trifluoroacetate salt and crystalline form b thereof, preparation methods and uses

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20200120

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20200120

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20201126

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20201201

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210217

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20210406

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20210427

R150 Certificate of patent or registration of utility model

Ref document number: 6877449

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE

Ref document number: 6877449

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250